Skip to content

Effects of L-theanine and GABA on sleep

Before-after study on the effects of L-theanine and GABA on sleep in adults with sleep problems. - Before-after study on the effects of L-theanine and GABA on sleep

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050613
Enrollment
20
Registered
2023-03-24
Start date
2023-03-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

L-theanine 200mg/day, gamma-aminobutyric acid 700mng/day for 4weeks

Sponsors

Hiroyuki Konno, Japan Brain-Care Dementia Prevention Research Center.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Females/males aged between 20 and 64 years who are aware of problems related to sleep. (2) Those with a BMI of between 18.5 and 25.0 kg/m2. (3) Those with a score of 6 or more on the Pittsburgh sleep quality index. (4) Those who are able to wear Fitbit Charge 5 during the study period, including at bedtime. (5) Those who can give written voluntary consent to participate in the study.

Exclusion criteria

Exclusion criteria: (1) Those who are currently diagnosed with insomnia or sleep disorders and are undergoing some kind of medical treatment. (2) Those who consume food or supplements containing L-theanine or gamma-aminobutyric acid. (3) Those who regularly use health foods or supplements that affect sleep. (4) Those with serious diseases such as glucose metabolism related disease, lipid metabolism related disease, liver disease, renal disease, cardiovascular disease, gastrointestinal disease, respiratory disease, hematological disease, autoimmune disease, endocrine system disease, metabolic system disease. Or those with a history of such diseases. (5) Those with a history of drug allergy or serious food allergy. (6) Those who have had abnormal laboratory values within the past year and have been considered to have problems participating in the study. (7) Those who have a disease that is currently undergoing medical visit, medical treatment, use of medication, or follow-up. (8) Those who are considered to be inappropriate as subjects based on the results of the questionnaire on the background of the subjects. (9) Those who are participating in other clinical studies at the start of this study. (10) Those who are pregnant or plan to become pregnant or breastfeed during the study period. (11) Those who are considered inappropriate to participate in the study by the study investigator (or the person in charge of the contract research organization).

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index

Secondary

MeasureTime frame
State-Trait Anxiety Inventory Health-related data collected by Fitbit Charge 5 Adverse event

Countries

Japan

Contacts

Public ContactKazumi Naganuma

DRC Co., LTD. Cosmetics and Food Usefulness Test Group, Testing Department

naganuma@drc-web.co.jp06-6882-1130

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026